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ATP synthaseWe recently reported that mitochondria-targeted derivatives of resveratrol are cytotoxic in vitro, selectively in-
ducingmostly necrotic death of fast-growing and tumoral cellswhen supplied in the low μMrange (N. Sassi et al.,
Curr. Pharm. Des. 2014). Cytotoxicity is due to H2O2 produced upon accumulation of the compounds into mito-
chondria. We investigate here the mechanisms underlying ROS generation and mitochondrial depolarization
caused by these agents. We ﬁnd that they interact with the respiratory chain, especially complexes I and III,
causing superoxide production. “Capping” free hydroxyls with acetyl or methyl groups increases their effective-
ness as respiratory chain inhibitors, promoters of ROS generation and cytotoxic agents. Exposure to the
compounds also induces an increase in the occurrence of short transient [Ca2+] “spikes” in the cells. This increase
is unrelated to ROS production, and it is not the cause of cell death. These molecules furthermore inhibit the F0F1
ATPase.When added to oligomycin-treated cells, the acetylated/methylated ones cause a recovery of the cellular
oxygen consumption rates depressed by oligomycin. Since a protonophoric futile cycle which might account for
the uncoupling effect is impossible, we speculate that the compounds may cause the transformation of the ATP
synthase and/or respiratory chain complex(es) into a conduit for uncoupled proton translocation. Only in the
presence of excess oligomycin the most effective derivatives appear to induce the mitochondrial permeability
transition (MPT) within the cells. This may be considered to provide circumstantial support for the idea that
the ATP synthase is the molecular substrate for the MPT pore.
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040.1. Introduction
Cancer cells have an altered redox homeostasis [1–5] and hyper-
polarizedmitochondria [6–9]. This latter characteristic is a consequence
of the shift frommitochondrial respiration to aerobic glycolytic ATP syn-
thesis (the so-called Warburg effect), which leads to reduced oxidative
phosphorylation activity, less efﬁcient dissipation of the mitochondrial
electrochemical proton gradient, and thus to an increased transmem-
brane potential [6,8]. ROS-generating agents targeted to mitochondria
thanks to conjugation with lipophilic cations (which accumulate in
the mitochondrial matrix according to the Nerst's law) have thus been
developed, and are emerging as a promising class of mitocans, i.e., anti-
cancer agents acting on mitochondria and destabilizing them [10,11].
Mitochondrial hyperpolarization leads to preferential accumulation of
the pro-oxidant agents in cancer cells. Furthermore, the additional oxi-
dative stress they cause may push cancerous cells over the brink of
death more easily than normal cells [2–5]. A recent paper has indeed
shown that healthy primary B cells can be sensitized to certain pro-
apoptotic drugs by induction of a mild mitochondrial oxidative stress
with a mitochondriotropic quercetin derivative. Conversely, cancerous
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with permeant ROS scavengers PEG-SOD and PEG-CAT [5].
We previously reported the synthesis and in vitro activity of a
group of resveratrol derivatives targeted to mitochondria via a 4-
triphenylphosphoniumbutyl (BTPI) group O-linked at either position
-3 or -4′ [12,13]. These derivatives, in the low-μM range, induced ne-
crotic cell death, selectively killing cancerous and fast-growing cells in
vitro [13]. Resveratrol itself has previously been shown to be cytotoxic,
but only at much higher doses (tens of μM) [14]. Mitochondrial
targeting thus appears to enhance the cytotoxicity exhibited by resver-
atrol itself. Cytotoxicity was found to be due to H2O2 produced upon ac-
cumulation of the derivatives into mitochondria; ROS-independent
mitochondrial depolarization was also induced. We investigate here
the mechanisms underlying these effects.
Since effectiveness increased if the two free hydroxyls of the deriva-
tives were acetylated or methylated [13], autooxidation of the polyphe-
nolic nucleus, which depends on the presence of free hydroxyls and is
favored by their ionization [15], could be excluded. Oxidation of the res-
veratrol “kernel” could be ruled out as the source of superoxide also
because cyclic voltammetry experiments showed that resveratrol and
its mitochondriotropic derivatives are not readily oxidizable at physio-
logically relevant voltages (Mattarei, A. et al., unpublished results). A
protonophoric cycle, such as that envisioned for mitochondriotropic
quercetin derivatives [16], can be dismissed as the cause of depolariza-
tion because of the lack of proton-carrying groups in themost effective,
methylated, molecules. Thus we thought that ROS were likely to be
generated downstream of the interaction of our molecules with redox-
active proteins. Themost likely candidateswere components of the respi-
ratory chain. Indeed some evidence for a modulation of respiratory chain
complexes by resveratrol has already been presented [17,18].
Ca2+ is a major second messenger modulating many cellular physi-
ological functions. Calcium and ROS are linked by a reciprocal interac-
tion: Ca2+ overload may cause ROS generation [19], and in turn ROS
may have an impact on Ca2+ homeostasis. Acute as well as chronic
oxidative stress can result in inhibition/downregulation/modulation of
the plasma membrane Ca2+ ATPase, reticular Ca2+ ATPase, Na+/Ca2+
exchanger, and other components of the Ca2+ homeostasis machinery
[20]. Depending on ROS levels, these effects may bemediated by the ac-
tion of redox-sensitive kinases, by direct modiﬁcation of the “pumps”
and transporters, or both [21].
Resveratrol is furthermore known to bind to the F1 portion of themi-
tochondrial ATP synthase inhibiting the enzyme [22–24]. We therefore
focused on Ca2+ levels and on ATPase functionality as well as on respi-
ration and ROS production.
2. Materials and methods
Experiments were repeated at least three times. Averages ± s.d. are
reported.
2.1. Materials
Resveratrol was purchased fromWaseta Int. Trading Co. (Shanghai,
P.R. China). R-4′BTPI, R-3BTPI, RDA-4′BTPI, RDA-3BTPI, RDM-4′BTPI
and RDM-3BTPI were synthesized as described in [12,13]. Other
chemicals were purchased from Sigma-Aldrich (Milan) unless other-
wise speciﬁed. All chemicals for buffer preparation were of laboratory
grade, obtained fromMerck, J.T. Baker or Sigma.
2.2. Cells and mitochondria
Mouse colon cancer CT-26 cells (doubling time 24 h)were grown in
high glucose (4.5 g/L) Dulbecco's Modiﬁed EagleMedium (DMEM) sup-
plemented with 10% (v/v) fetal bovine serum (FBS, Invitrogen), 10 mM
HEPES buffer (pH 7.4), 1 mM sodium pyruvate, 100 U/mL penicillin G,
0.1 mg/mL streptomycin, 2mMglutamine (GIBCO) and 1%nonessentialamino acids (100× solution; GIBCO), in a humidiﬁed atmosphere of
5% CO2 at 37 °C.
Rat liver mitochondria (RLM) were isolated by conventional differ-
ential centrifugation procedures [25]. The standard isolation medium
was: 250 mM sucrose, 5 mMHEPES, 1 mM EGTA (pH 7.4). Protein con-
tent was quantiﬁed with a BCA Protein Assay Kit (Thermo Scientiﬁc)
using an albumin calibration curve.
2.3. Fluorescence microscopy
AnOlympus Biosystems apparatus comprising an Olympus IX71mi-
croscope and MT20 light source was used; images were acquired auto-
matically at 1-min intervals for 70 min, and processed with CellR®
software. CT-26 cells were seeded on a XF24-well microplate at a densi-
ty of 5 × 104 cells/well in DMEM + FBS 10% (200 μL) and incubated
overnight in a humidiﬁed atmosphere with 5% CO2 at 37 °C. Cells
were then washed with HBSS (in mM units: NaCl 136.9, KCl 5.36,
CaCl2 1.26, MgSO4 0.81, KH2PO4 0.44, Na2HPO4 0.34, glucose 5.55,
pH 7.4 with NaOH) and loaded with dye. All experiments were per-
formed in DMEM without Phenol red and FBS, at room temperature.
2.3.1. Intracellular Ca2+ levels
The non-ratiometric dye Fluo-4 was used to follow [Ca2+] changes
in cultured cells under the same experimental conditions used in oxy-
gen consumption assays. Cells were loaded with 20 nM Fluo-4 methyl
ester, in the presence of 0.04% Pluronic acid, 100 μM Probenecid and
2 μM CsA, at 37 °C for 30 min. The medium was then replaced with
670 μL of pre-warmed (37 °C) DMEM supplemented with 0.04%
Pluronic acid, 100 μM Probenecid and 2 μM CsA; cells were then incu-
bated for 30 min at 37 °C to allow complete hydrolysis of Fluo-4 ester
bonds. Excitation wavelength was 480–500 nm and ﬂuorescence was
collected at λ N 510 nm. Additions were performed by withdrawing
0.5 mL of incubation medium, adding to this aliquot the desired com-
pound as a solution in 70 μL of DMEM and adding back the solution
into the chamber at a peripheral point.
2.3.2. O2
−• generation
O2−• generation in cells was followed using MitoSOX Red™ (Life
Technologies). CT-26 cells were loaded with 1 μM MitoSOX Red™, in
the presence of 2 μM CsA, at 37 °C for 30 min. The medium was then
replaced with 670 μL of pre-warmed (37 °C) DMEM containing 2 μM
CsA. Excitation was at 500–520 nm, and ﬂuorescence was collected at
λ N 570 nm. Additions were performed as described above.
2.4. Oxygen consumption assay by CT-26 cells
Respiration by adherent cells was measured using a Seahorse XF24
(Seahorse Bioscience) which measures the oxygen consumption rate
(OCR) in themedium immediately surrounding adherent cells cultured
in an XF24-well microplate. Adherent CT-26 cells were seeded at a den-
sity of 5 × 104 cells/well in DMEM + FBS 10% (200 μL) and incubated
overnight in a humidiﬁed atmosphere with 5% CO2 at 37 °C. The medi-
umwas then replaced with 670 μL of pre-warmed (37 °C) high-glucose
DMEM supplemented with 1 mM sodium pyruvate, 4 mM L-glutamine,
and without FBS. Microplates were incubated at 37 °C for 30 min to
allow temperature and pH to stabilize before the measurements. OCR
was measured at preset time intervals while the instrument auto-
matically carried out the pre-programmed additions of the various
compounds (ﬁnal concentrations unless otherwise speciﬁed:
oligomycin A 1 μg/mL, FCCP 0.2 μM, antimycin A 1 μM), added as a
solution in 70 μL of DMEM. All measurements were carried out in
quadruplicate (4 wells per condition). For presentation purposes
the data were normalized to the initial OCR baseline measurement
for each set of wells and are presented as % changes with respect
to that level. ECAR (extracellular acidiﬁcation rate) was also auto-
matically measured during the same experiments.
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Complex activity was extrapolated from the slope of absorbance de-
crease; data are expressed as % of the control (i.e., the activity without
any addition of the derivative).2.5.1. Complex I activity
To assay NADH-CoQ oxidoreductase (complex I) activity, RLM
(50 μg prot./mL) were incubated with 10 μM alamethicin, 3 mg/mL bo-
vine serum albumin (BSA), 10mMTris–HCl (pH 8.0), 2.5mMNaN3 and
65 μM coenzyme Q1 (CoQ1). The reaction was started with the addition
of 100 μM NADH. Changes in absorbance (340 nm) were monitored at
37 °C using an Agilent Technologies Cary 100 UV–Vis spectrophotome-
ter. After 6 min, 2 μM rotenone was added to assess the rotenone- (and
thus complex I-) independent activity to be subtracted.2.5.2. Complex II activity
Tomeasure succinate CoQ oxidoreductase (complex II) activity, RLM
(5 μg prot./mL) were incubated in the assay medium (potassium
phosphate 25 mM, pH 7.5, supplemented with 5 mM MgCl2, 20 mM
succinate and 10 μM alamethicin) at 30 °C for 10 min. 3 mg/mL BSA,
2.5 mM NaN3, 2 μg/mL antimycin A, 2 μM rotenone, and 125 μM 2,6-
dichlorophenolindophenol (DCPI) were then added and absorbance
changes were monitored at 600 nm.2.5.3. Complex III activity
To assay CoQ cytochrome c oxidoreductase (complex III) activity,
RLM (10 μg prot./mL) were added to a cuvette containing 50mMpotas-
sium phosphate buffer, pH 7.5, supplemented with 10 μM alamethicin,
3 mg/mL BSA, 2.5 mM NaN3, 2 μM rotenone, 0,025% TWEEN, and
75 μM oxidized cytochrome c. The reaction was started adding 75 μM
of reduced decylubiquinol (produced by reduction of decylubiquinone
in ethanol with NaBH4 shortly before use); changes in absorbance
were monitored at 550 nm, 37 °C. After 6 min, 2 μg/mL antimycin was
added for assessment of the antimycin-dependent complex III enzyme
activity.2.6. F0F1 ATPase activity
Mitochondrial F0F1 ATPase activity was measured by coupling the
production of ADP to the oxidation of NADH via the pyruvate kinase
and lactate dehydrogenase reaction (coupled assay), as described
in [26]. The reaction mixture (pH 7.6) contained 250 mM sucrose,
10 mM Tris–HCl, 200 μM EGTA–Tris, 1 mM NaH2PO4, 6 mM MgCl2,
2 μM rotenone, 10 μM alamethicin, 3 mg/mL BSA, 1 mM phosphoenol-
pyruvate (PEP), 0.1 mM NADH, pyruvate kinase (PK; 20 units/mL),
lactate dehydrogenase (LDH; 50 units/mL), and RLM (20 μg prot./mL).
Absorbance was measured at 340 nm, 25 °C. The reaction was started
by the addition of 500 μM ATP; after 6 min, 1 μg/mL oligomycin A was
added to evaluate F0F1-ATPase-independent ATP hydrolysis.Fig. 1.Mitochondriotropic resv3. Results
Since H2O2 is responsible for cell death induction by mito-
chondriotropic resveratrol derivatives [13], the mechanisms underlying
ROS generation were investigated using cultured cells and isolated rat
livermitochondria. All tested compounds are illustrated in Fig. 1; both iso-
mers were used, bearing the 4-triphenylphosphoniumbutyl (BTPI) group
at either position -3 or -4′.3.1. Effects on intracellular Ca2+ levels. Ca2+ signalling does not have a role
in cytotoxicity
Since ROS and Ca2+ signalling can be linked [19–21], we evaluated
the effects of treatment with the most cytotoxic compounds, RDM-
3BTPI and RDM-4′BTPI (5 μM), on CT-26 cellular Ca2+ levels. The two
isomers had very similar effects; observations obtained with RDM4′-
BTPI are illustrated in Fig. 2A–C. The Ca2+probe Fluo-4was used inﬂuo-
rescence microscopy experiments conducted under the same condi-
tions used in the experiments on cellular respiration (SeaHorse; see
Section 3.3). Ionomycin was used as a control to make sure that the
Fluo-4 probe was responding adequately to Ca2+, and to determine
the maximum Fluo-4 ﬂuorescence response. In control experiments
(i.e., untreated cells), less than 1% of the cell population displayed spo-
radic (generally one or two per cell) brief (≤1 min) increases of intra-
cellular [Ca2+] during the one-hour monitoring period. The effect of
the resveratrol derivatives was to increase from b1% to ~5% the fraction
of cells displaying these [Ca2+] “spikes”. These occurred randomly, but
with a preference for late times after addition of the derivative
(N40 min). They did not impair the ability of the cell to take up Ca2+
upon the introduction of ionomycin at the end of the experiment.
Occurrence of the [Ca2+] transients was not downstream of ROS
production, since the presence of PEG-SOD and PEG-CAT had no effect
on their prevalence, intensity or multiplicity (Fig. 2C). PEG-SOD and
PEG-CAT were proven, however, to efﬁciently reduce ROS generation
under these same experimental conditions (Fig. 2F).
Superoxide production was observed in ﬂuorescence microscopy
experiments using the MitoSOX™ probe (Fig. 2D–F). Under the same
experimental conditions as in Fig. 2A–C, superoxide generation in-
creased in all cells (Supplementary Fig. 1), beginning shortly after the
addition of the mitochondriotropic derivatives (Fig. 2D). On the other
hand, brief calcium spikes occurred only in a small fraction of cells,
and with a random delay after compound addition (Fig. 2B and C).
The comparison of the time course and prevalence of the two phenom-
ena allows one to conclude that ROS productionwas not downstreamof
themodest Ca2+ signals. Note that the response elicited by antimycin A
(Fig. 2E) was similar to that caused by RDM-4′BTPI (Fig. 2D), and that
the two were not additive (Fig. 2D). The presence of cell-permeant
PEG-SOD and PEG-CAT eliminated theMitoSOX™ ﬂuorescence increase
elicited by RDM-4′BTPI (Fig. 2F), conﬁrming on one side that it is due to
mitochondrial ROS, and on the other that the enzymes added effectively
scavenge O2• /H2O2. The behavior shown in Fig. 2F is completely analo-
gous to that exhibited by MitoSOX™-loaded but otherwise untreated
(control) cells (not shown).eratrol derivatives studied.
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Fig. 2. Effects of RDM-4′BTPI on intracellular Ca2+ levels (A–C) and O2−• generation (D–F). A–C: Fluorescence microscopy experiments with Fluo-4 loaded CT-26 cells. A: an image (λexc:
492 nm; λem N 510 nm) acquired 30min after addition of 5 μMRDM-4′BTPI; B: computer-generated plots of the ﬂuorescence emitted by the regions of interest (ROI) identiﬁed in panel A,
with background subtraction. The behavior of 4 cells displaying Ca2+ spikes is reported. 5 μM RDM-4′BTPI and 2.5 μM ionomycin were added when indicated. C: Overall extent of the
phenomenon, expressed as % of cells exhibiting [Ca2+] spikes within 1 h, out of the total cell population. Averages ± s.d. are reported. D–F: Fluorescence microscopy experiments with
MitoSOX™-loaded CT-26 cells. Computer-generated plots of the ﬂuorescence emitted by some regions of interest (ROI); each ROI was selected to enclose one cell. The behavior of
5 representative cells is reported. 5 μM RDM-4′BTPI and/or 1 μg/mL antimycin A were added when indicated. F: PEG-SOD (40 U/mL) and PEG-CAT (500 U/mL) were present from the
beginning.
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A possible rationalization of superoxide generation by our deriva-
tives is that they may interfere with respiration, diverting part of the
electron ﬂow to superoxide production. We veriﬁed their effect on the
rate of fully uncoupled (by FCCP) respiration by CT-26 cells; a high con-
centration (50 μM) was used, to roughly compensate for the lack of ac-
cumulation due to the dissipation of the transmembrane potential by
FCCP. The compounds did decrease the rate of oxygen consumption
(Fig. 3); this indicates that they can interactwith respiratory chain com-
ponents. This interaction seems to be favored by “masking” of the free
hydroxyls with methyl or acetyl groups. Resveratrol itself caused only
a modest inhibition, while rotenone and antimycin produced the ex-
pected drastic respiratory decrease, similar in extent to that observed
with RDM-BTPIs (Supplementary Fig. 2).
To conﬁrm respiratory chain inhibition and ROS generation bymito-
chondria we performed measurements of oxygen consumption andROS generation with isolated rat liver mitochondria (RLM). The experi-
ments conﬁrmed the inhibitory effect on respiration driven by complex
I (glutamate/malate) or complex II (succinate/rotenone) substrates.
FACS analysis of isolated rat liver mitochondria loaded with H2DCF-DA
conﬁrmed that our compounds cause ROS production by mitochondria
energized either via complex I or complex II (Supplementary Fig. 3).
We thus veriﬁed the effect of our derivatives on the activity of the in-
dividual complexes, using alamethicin-permeabilized RLM. Also in this
case, to roughly simulate the concentration of mitochondriotropic de-
rivatives in the presence of aΔψm (which in these experiments was dis-
sipated by permeabilization), the compounds were also used at 50 μM
(Fig. 4B). Under these latter conditions inhibition of respiratory chain
complexes was found to be signiﬁcant in most cases, as assessed by
the Mann–Whitney test. The observed effects however differed consid-
erably in magnitude; we focus here only on the most signiﬁcant ones
(i.e. those inducing at least 30% activity inhibition). Complexes I and III
were particularly inhibited, and methylated derivatives were the most
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Fig. 3. Effect of mitochondriotropic resveratrol derivatives on the rate of respiration fully
stimulated by FCCP. Rates of respiration by CT-26 cells were determined using a Seahorse
XF24. Representative experiments are shown. Derivatives (50 μM) were added to cells
after 0.2 μM FCCP. Data were normalized to the initial FCCP-elicited OCR for each set of
wells and are presented as % changes with respect to that level.
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and complex III (both isomers) even at 5 μM (Fig. 4A). Resveratrol itself
was shown to signiﬁcantly inhibit only complex I, and only when used
at 50 μM. This effect is much weaker compared to the inhibitory effects
obtained with acetylated or methylated mitochondriotropic derivatives
at the same concentration (about 20% inhibition vs 60–90% inhibition).
3.3. Effects on cellular oxygen consumption
5 μM R-3BTPI or R-4′BTPI had little effect on the rate of oxygen con-
sumption by otherwise untreated CT-26 cells in experiments with
Seahorse XF24 (Fig. 5A). Under the same experimental conditions,
only RDM-4′BTPI reduced respiration (Fig. 5C), while RDA-3BTPI,
RDA-4′BTPI and RDM-3BTPI induced relatively minor perturbations
(Fig. 5B, C). However, all these four compounds drastically reduced
the respiratory response to the subsequent addition of oligomycin and
FCCP (Fig. 5A–C). A massive loss of cells due to death and detachment
was excluded by direct microscopic observation of the cells at the end
of the experiments. On the other hand, if the respiration rate was ﬁrst
reduced using the ATP synthase inhibitor oligomycin A, the subsequent
addition of RDA-3BTPI, RDA-4′BTPI, RDM-3BTPI or RDM-4′BTPI induced
an increase in oxygen consumption (respiratory “recovery”), which
could hardly be further increased by the uncoupler FCCP, but was sensi-
tive to antimycin A, an inhibitor of the mitochondrial respiratory chain
(complex III) (Fig. 5E, F), thus conﬁrming that the increase was due to
respiration. R-3BTPI and R-4′BTPI had little effect in this experimental
setup as well (Fig. 5D). Respiration rates in the presence of both the
mitochondriotropic derivative and oligomycin were, as may be expect-
ed, similar irrespective of the order of addition.Fig. 4. Effects of resveratrol and its mitochondriotropic derivatives on the activity of the indicated
Concentration of the derivatives was 5 μM (A) or 50 μM (B).Given the presence of oligomycin and the known interaction of res-
veratrol with the mitochondrial F0F1 ATP synthase [24,27], we initially
hypothesized that the synthasemayhave a role in the respiratory recov-
ery, and veriﬁed whether the compounds might be competing with
oligomycin, displacing it and re-activating the enzyme. However, in-
creasing oligomycin dosages did not prevent ormarkedly reduce the ex-
tent of the recovery; rather, with high oligomycin (3 or 10 μg/mL) there
was a subsequent decline of the rate of respiration (Fig. 6 and Supple-
mentary Fig. 4), which could not be rescued by FCCP, while antimycin
A inhibitedwhat respirationwas left. The higher the dose of oligomycin,
the more pronounced this second-stage respiratory decline, which was
furthermore not affected by elimination of H2O2with PEG-CAT (Supple-
mentary Fig. 4). High concentrations of oligomycin alone caused the ex-
pected decrease of cellular respiration, which remained depressed
indeﬁnitely, without any recovery resembling that observed upon the
further addition of an acylated or methylated mitochondriotropic res-
veratrol derivative.
The behaviour elicited by RDM-4′BTPI was again, to an extent, dis-
crepant. With this compound the respiratory recovery in the presence
of oligomycin was less pronounced than with the other compounds
(Fig. 5F), and oxygen consumption after the recovery in the presence
of high oligomycin declined less markedly (Fig. 6). RDM-4′BTPI is the
most powerful inhibitor of complex I (Fig. 4) and the only compound
which decreased OCR by untreated cells at the 5 μM level (Fig. 5C).
The lower extent of respiratory recovery might thus be due to a more
pronounced inhibition of the respiratory chain.
The secondary decrease of oxygen consumption at high oligomycin
dosages is reminescent of an analogous phenomenon which often fol-
lows induction of the mitochondrial permeability transition (MPT),
and is attributed to loss of respiratory intermediates via the MPT pore.
We thus performed the same experiments in the presence of CsA, and
found that the oxygen consumption rate was partially rescued by CsA
when high oligomycin concentrations were used, indicating that the
MPT may indeed be taking place and may at least partially account for
the observations (Fig. 6). The effect is particularly evident in the case
of derivatives bearing the -BTPI at position -3 of the stilbene skeleton
(RDA-3BTPI and RDM-3BTPI) (Fig. 6A and C). On the other hand, we
conﬁrmed that MPTwas not involved in cell death induced by our com-
pounds alone, since CsA had no impact on the readout of MTT assays
(Supplementary Fig. 5).
3.4. Interactions with the F0F1 ATP synthase
The effect of high oligomycin suggests an involvement of the F0F1
ATP synthase. Indeed, resveratrol itself is known to bind to the F1 por-
tion of this multimeric enzyme complex [24]. We checked the effect of
the resveratrol derivatives on the hydrolytic activity of the RLM ATP
synthase. Experiments were performed using isolated RLM in therespiratory chain complexes, in permeabilized RLM. Averages ± s.d. are reported (N= 3).
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Fig. 5. Effects of mitochondriotropic resveratrol derivatives on the respiration of cultured cells. Rate of respiration by CT-26 cells as determined using Seahorse XF24. Representative
experiments are shown. 5 μM of the indicated compounds was added to cells before (A, B, C) or after (D, E, F) the addition of 1 μg/mL oligomycin. A, D: resveratrol and non-acetylated/
methylated derivatives; B, E: acetylated derivatives; C, F: methylated derivatives.
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to externally added reagents and also causes complete depolarization.
Acetylated and methylated derivatives, as well as resveratrol, turned
out to be inhibitors of the ATPase at 50 μM, while R-3BTPI and R-4′
BTPI did not (Fig. 7).
ATPase inhibition by RDA-BTPIs and RDM-BTPIswas associatedwith
an increase in the glycolytic activity of the cells, as shown by increased
extracellular acidiﬁcation rate (ECAR) after addition of RDA- or RDM-
BTPIs (Supplementary Fig. 6).
4. Discussion
In our previous work with mitochondriotropic resveratrol deriva-
tives [13] we had established that cell death is caused by H2O2, generat-
ed following accumulation of the compounds in mitochondria. Datapresented above conﬁrm this, indicating that cell death is not a conse-
quence of Ca2+ dysregulation (Fig. 2) or of MPT occurrence (Supple-
mentary Fig. 5). The compounds did increase the (low) probability of
observing transient [Ca2+] “spikes” in treated cells, but a relationship
between this increase and the induction of cell death can be excluded
because the [Ca2+] spikes remained anyhow rare and were observed
only in a small percentage of cells, and because death-abolishing
membrane-permeant radical scavangers PEG-SOD + PEG-CAT had no
effect on the [Ca2+] transients. Our previous observations [13] had fur-
thermore suggested that superoxide anion, the precursor of H2O2,might
be formed by “slipping” complexes of the respiratory chain, which
would transfer single electrons to oxygen molecules upon interaction
with the compounds. This model is supported by the observation that
RDA-BTPIs and RDM-BTPIs inhibit FCCP-uncoupled respiration of CT-
26 cells (Fig. 3). More speciﬁcally, experiments with RLM indicate that
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Fig. 6.Acetylated andmethylatedmitochondriotropic resveratrol derivatives affect respiration in an oligomycin-dependentmanner. Rate of respiration by CT-26 cells as determined using
Seahorse XF24. Representative experiments are shown. 5 μM of the indicated derivative was added to cells after inhibition of ATP synthase activity with oligomycin 1 μg/mL (OL 1) or
10 μg/mL (OL 10). The effect on respiration of the presence of CsA (2 µM) from the beginning of the experiment is also shown.
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RDM-4′BTPI are themost powerful inhibitors; they are about equally ef-
fective on complex III, while RDM-4′BTPI appears to act more strongly
than its isomer on complex I. These two complexes are known to be
the major source of ROS in normal respiring mitochondria, and it is
plausible that themitochondriotropic compoundsmay elicit an increase
of this side reaction, analogously to what happens in the case of com-
plex II and vitamin E analogs [28]. The methylated derivatives are also,
along with RDA-3BTPI, the most powerful inducers of superoxide pro-
duction [13]. This correlation between inhibition of respiratory chain
complexes and production of superoxide supports the notion that ROS
production is a consequence of the interaction of the compounds with
the complexes.Fig. 7. Effects of resveratrol and its mitochondriotropic derivatives on the rate of ATP
hydrolysis by permeabilized RLM. Averages ± s.d. are reported (N = 3).In the same concentration range, the RLM F0F1 ATPase is also
inhibited (Fig. 7). The four compounds with all hydroxyls capped by a
substituent appear to be about equally effective. Resveratrol and other
stilbene derivatives are known to interact with the F1 portion, binding
in a pocket formed by the γ and βTP subunit and thereby blocking rota-
tion ([27] and refs therein).
The higher efﬁciency of acetylated and methylated compounds as
inhibitors and as inducers of ROS production may reﬂect a better parti-
tion into membranes and/or a higher afﬁnity for the enzymes involved
(see [29]). Please note that acetylated derivativesmayundergo hydroly-
sis with rates dependent on conditions, regenerating R-3BTPI and R-4′
BTPI [13].
These inhibitory properties largely account for the observationswith
cultured cells. In this system at least three counteracting effects of our
compounds are expected to modulate oxygen consumption: inhibition
of the respiratory chain and of the F0F1 ATP synthase (which when in
operation stimulates respiratory activity via its effects on Δμ̃H) will
tend to lower respiration while dissipation of Δμ̃H [13] will tend to in-
crease it. That ATP synthesis is hardly contributing to respiration after
a one-hour exposure to 5 μM RDA- and RDM-derivatives is shown by
the smallness of the effect of oligomycin (Fig. 5). That respiration is
close to having exhausted its “reserve capacity” (e.g. [30]) is indicated
by the lack, or near-lack of effect by FCCP (Fig. 5B–C). RDM-4′BTPI is
the only compound causing a pronounced decrease of respiration by
otherwise untreated CT-26 cells (Fig. 5C). This might in principle be
due to a better inhibition of the ATP synthase or to a less pronounced
Δψm dissipation. The data however rule these hypotheses out (Fig. 7
and [13]), leaving its greater effectiveness as an inhibitor of complex I
as the plausible reason.
Measurements of respiratory rates in the presence of variable con-
centrations of oligomycin A, a polyketide inhibitor of the mitochondrial
F0F1 ATP synthase acting at the interface between the c-ring and subunit
1788 N. Sassi et al. / Biochimica et Biophysica Acta 1837 (2014) 1781–1789a [27], point to a further mode of action of the acetylated and in partic-
ular of themethylated compounds. If cellular respiration has previously
been depressed by oligomycin, their addition induces a recovery of the
respiratory rate (Fig. 5E, F). This may be simply a reﬂection of the loss of
Δψm induced by them, the mechanism of which remains to be elucidat-
ed. By the tenets of the chemiosmotic model, depolarization with asso-
ciated respiratory stimulation is likely to reﬂect the appearance of a
Δψm-dissipatingproton leak. Since our derivatives interactwith respira-
tory chain complexes andwith the ATP synthase, it seems logical to pro-
pose that this proton leak may result from a functional uncoupling of
the former or, more likely, the latter. In other words, we suggest that
binding to complex V our compounds may not only inhibit ATP hydro-
lysis (and presumably synthesis), but also transform the ATP synthase
into a conduit for a proton ﬂux not associated with ATP synthesis/
hydrolysis (“intrinsic uncoupling” or “proton slip”). Indeed the ATP syn-
thase has been proposed to be able to conduct a “proton slip”, a process
possibly induced by isoﬂurane [31] or 17 β-estradiol [32] and modulated
by Bcl-xL [33].
In this context it is of interest that at higholigomycin doses the respi-
ratory recovery is followed by a CsA-sensitive decline (Fig. 6), which
suggests the onset, in a stilbenoid-induced and oligomycin-sensitive
process, of the permeability transition. By itself, oligomycin decreases
cellular respiration due to ATP synthase inhibition, but has no further ef-
fects in the concentration range used in this work. In the literature on
the MPT oligomycin is considered to be, if anything, a protective agent
[34]. It follows that in our experimental system MPT pore opening can
be mediated by membrane component(s) sensitive to the presence of
both our mitochondriotropic derivatives and oligomycin. It seems logi-
cal to think of the ATP synthase. In the presence of excess oligomycin,
the putative uncoupling ATP synthase-mediated “proton slip” may be-
come a canonical, CsA-sensitive MPT. That development of the MPT
pore may be preceded by a “small pore” phase, in which the membrane
is permeable only to small ions, has been proposed in a number of pa-
pers [34–38]. It has been recently argued on the basis of electrophysio-
logical and biochemical evidence that the ATP synthase dimer may be
responsible for the generation of the MPT pore [39,40]. One point inFig. 8. Proposed mechanisms of cytotoxic action of mitochondfavor of this model is the fact that the MPT pore has long been proposed
to have a dimeric structure on the basis of patch-clamp recordings [34,
41,42]. Our observations are therefore coherent with the emerging mo-
lecular model of the pore and reinforce it. Fig. 8 presents our working
model of the cytotoxic action of mitochondriotropic resveratrol deriva-
tives on cells. Again, while uncoupling and inhibition of the ATP synthase
may well be expected to eventually lead to cell death, the most rapidly
acting agent is the H2O2 produced. We would also like to emphasize
that the onset of the MPT is only inferred to take place in our system
when excess oligomycin is also provided. Judging from the lack of sensi-
tivity of cell death to CsA (Supplementary Fig. 5), the MPT appears
not to be the proximal cause of cell death induction by our mito-
chondriotropic resveratrol derivatives alone. The latter take in any case
a front-line position in the ranks of redox-active potential “mitocans”.
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